Risk of multiple sclerosis during tumour necrosis factor inhibitor treatment for arthritis: a population-based study from DANBIO and the Danish Multiple Sclerosis Registry

L Dreyer; M Magyari; B Laursen; René Lindholm  Cordtz; F Sellebjerg; H Locht

doi:10.1136/annrheumdis-2015-208490

Risk of multiple sclerosis during tumour necrosis factor inhibitor treatment for arthritis: a population-based study from DANBIO and the Danish Multiple Sclerosis Registry

L Dreyer, M Magyari, B Laursen, René Lindholm Cordtz, F Sellebjerg, H Locht

31 Citations (Scopus)

Original language	English
Journal	Annals of the Rheumatic Diseases
Volume	75
Issue number	4
Pages (from-to)	785-6
ISSN	0003-4967
DOIs	https://doi.org/10.1136/annrheumdis-2015-208490
Publication status	Published - 23 Dec 2016

Access to Document

10.1136/annrheumdis-2015-208490

Cite this

@article{56b46ca1040943648c78aba98da340c4,

title = "Risk of multiple sclerosis during tumour necrosis factor inhibitor treatment for arthritis: a population-based study from DANBIO and the Danish Multiple Sclerosis Registry",

author = "L Dreyer and M Magyari and B Laursen and Cordtz, {Ren{\'e} Lindholm} and F Sellebjerg and H Locht",

year = "2016",

month = dec,

day = "23",

doi = "10.1136/annrheumdis-2015-208490",

language = "English",

volume = "75",

pages = "785--6",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "B M J Group",

number = "4",

}

TY - JOUR

T1 - Risk of multiple sclerosis during tumour necrosis factor inhibitor treatment for arthritis

T2 - a population-based study from DANBIO and the Danish Multiple Sclerosis Registry

AU - Dreyer, L

AU - Magyari, M

AU - Laursen, B

AU - Cordtz, René Lindholm

AU - Sellebjerg, F

AU - Locht, H

PY - 2016/12/23

Y1 - 2016/12/23

U2 - 10.1136/annrheumdis-2015-208490

DO - 10.1136/annrheumdis-2015-208490

M3 - Letter

C2 - 26698850

VL - 75

SP - 785

EP - 786

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - 4

ER -